Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Elisa Eleanor Cornish, Kelvin Yi Chong Teo, Mark C. Gillies, Lyndell L. Lim, Ian McAllister, Sutha Sanmugasundram, Vuong Nguyen, Sanjeewa Wickremasinghe, Hemal Mehta, Samantha Fraser-Bell

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages2
JournalInvestigative ophthalmology & visual science
Volume59
Issue number9
Publication statusPublished - Jul 2018
EventAnnual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO): ARVO Annual Meeting 2018 - Hawaii Convention Center, Honolulu, United States
Duration: 29 Apr 20183 May 2018

Cite this

Cornish, E. E., Teo, K. Y. C., Gillies, M. C., Lim, L. L., McAllister, I., Sanmugasundram, S., Vuong Nguyen, Wickremasinghe, S., Mehta, H., & Fraser-Bell, S. (2018). Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone). Investigative ophthalmology & visual science, 59(9).